Tag: Multidistrict Litigation
-
Prilosec / Prevacid / Nexium Federal Court Lawsuits For Kidney Injury Consolidated By MDL Established In August 2017
These Proton-Pump Inhibitors (PPIs) Are Linked To Acute Interstitial Nephritis, Chronic Kidney Disease, End Stage Renal Disease, And Kidney Failure (Posted by Tom Lamb at DrugInjuryWatch.com) In February 2017 the United States…
-
Federal Court Invokana MDL: Judge Martinotti Is Presiding Over These Drug Injury Lawsuits In New Jersey
A December 2016 Judicial Panel for Multidistrict Litigation (JPML) Order Consolidated All Invokana And Invokamet Cases (Posted by Tom Lamb at DrugInjuryWatch.com) In September 2016, pursuant to 28 U.S.C. ยง 1407, a…
-
Pending Motion Requests Multidistrict Litigation (MDL) For Farxiga And Xigduo XR Lawsuits Filed In Federal Court
These New Diabetes Drugs Have Increased Risks Of Serious Side Effects Such As Diabetic Ketoacidosis (DKA) And Acute Kidney Injury (Posted by Tom Lamb at DrugInjuryWatch.com) Farxiga (dapagliflozin) and Xigduo XR (dapagliflozin…
-
Drug Companies Bristol-Myers Squibb And Pfizer Ask For Consolidation Of Eliquis Lawsuits In Federal Court Multidistrict Litigation Case
Filed In October 2016, Defendants' MDL Motion Requests 34 Eliquis Cases Be Transferred To U.S. District Judge Lewis A. Kaplan In Southern District Of New York (Posted by Tom Lamb at DrugInjuryWatch.com) …
-
Viagra MDL Petition Seeks Consolidation Of All Federal Court Lawsuits Against The Pharmaceutical Company Pfizer Filed By Patients Who Have Developed Melanoma
Viagra Has Been Associated With A Higher Incidence Of Invasive Melanoma, A Side Effect Which May Also Be Linked To Cialis, Levitra, And Similar ED / BPH / PAH Drugs (Posted by Tom…
-
October 2009: Yasmin And Yaz Multidistrict Litigation (MDL) Transfer Order For Injury And Death Cases Filed In Federal Court
MDL No. 2100 — IN RE: Yasmin and Yaz (Drospirenone) Marketing and Sales Practices and Products Liability Litigation — Assigned To Southern District of Illinois (Posted by Tom Lamb at DrugInjuryWatch.com) _____________________________________________________________________ UPDATE: Our Focus…